|
1
|
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
|
J Clin Oncol
|
2008
|
18.54
|
|
2
|
Histone deacetylase inhibitors.
|
Adv Cancer Res
|
2004
|
2.93
|
|
3
|
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
|
J Clin Oncol
|
2004
|
2.04
|
|
4
|
The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
|
Oncology (Williston Park)
|
2016
|
1.37
|
|
5
|
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.
|
Cancer Lett
|
2011
|
0.99
|
|
6
|
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
|
Cancer
|
2013
|
0.98
|
|
7
|
Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer.
|
Expert Rev Endocrinol Metab
|
2011
|
0.96
|
|
8
|
Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.
|
Urology
|
2002
|
0.86
|
|
9
|
An Internet intervention for management of uncertainty during active surveillance for prostate cancer.
|
Oncol Nurs Forum
|
2011
|
0.81
|
|
10
|
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
|
Urology
|
2004
|
0.76
|
|
11
|
New treatment options for castrate-resistant prostate cancer: a urology perspective.
|
Can J Urol
|
2011
|
0.76
|
|
12
|
Dysregulated methylation at imprinted genes in prostate tumor tissue detected by methylation microarray.
|
BMC Urol
|
2013
|
0.76
|
|
13
|
High-dose bicalutamide after radiotherapy for locally advanced prostate cancer: a standard of care?
|
Nat Clin Pract Urol
|
2007
|
0.75
|
|
14
|
Bisphosphonates for men with prostate cancer: sifting through the rubble.
|
J Clin Oncol
|
2003
|
0.75
|
|
15
|
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
|
J Urol
|
2007
|
0.75
|
|
16
|
Use of nomograms for predicting survival in patients with castrate prostate cancer.
|
Urology
|
2003
|
0.75
|